China Shineway Pharmaceutical Group Limited

CSWYYOTCHealthcare● Active

$19.25

+$0.00(+0.00%)

Market Cap$36353625

P/E Ratio—

52W High$22.54

52W Low$19.25

Avg Volume0.584

Open$22.08

Beta0.71

Overview

China Shineway Pharmaceutical Group Limited (CSWYY) Earnings: Dates, EPS & Revenue History

Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.

CSWYY · earnings · updated Jun 9, 2026

Latest Earnings

Q1 FY2026Report Date: Mar 26, 2026

EPS Actual

$24.99

Revenue

$0.21B

Fiscal Period

Q1 FY2026

FY ends December

Report Date

Mar 26, 2026

After Market Close

CSWYY reports quarterly as a OTC-listed Drug Manufacturers - Specialty & Generic company. Fiscal year ends in December. Data: FMP · Updated hourly.

Next Earnings Date

Days Away

days

Expected Date

Sep 1, 2026

Fiscal Period

Q3 FY2026

Release Time

◌ Time TBD (Unconfirmed)

EPS Est.

—

Days Away84

Expected DateSep 1, 2026

Fiscal PeriodQ3 FY2026

Release TimeTime TBD (Unconfirmed)

EPS Est.—

EPS & Revenue vs. Estimates

Actual (Beat)

Actual (Miss)

Estimated

Earnings History

Period	Report Date	EPS Est.	EPS Actual	EPS Surpr.	Revenue	Rev. Est.	Rev. Surpr.
— Q1 FY2026	Mar 26, 2026	—	$24.99	—	$0.21B	—	—
◌ Q3 FY2025	Sep 1, 2025	—	—	—	—	—	—
◌ Q1 FY2025	Mar 26, 2025	—	—	—	—	—	—
◌ Q3 FY2024	Aug 29, 2024	—	—	—	—	$0.80B	—
◌ Q1 FY2024	Mar 28, 2024	—	—	—	—	—	—
— Q4 FY2023	Dec 31, 2023	—	$35.74	—	$0.30B	—	—
— Q2 FY2023	Jun 30, 2023	—	$35.92	—	$0.33B	—	—
— Q4 FY2022	Dec 31, 2022	—	$30.29	—	$0.31B	—	—

Q1 FY2026

Mar 26, 2026

EPS Actual

$24.99

EPS Est.

—

EPS Surpr.

—

Revenue

$0.21B

Q3 FY2025

Sep 1, 2025

EPS Actual

—

EPS Est.

—

EPS Surpr.

—

Revenue

—

Q1 FY2025

Mar 26, 2025

EPS Actual

—

EPS Est.

—

EPS Surpr.

—

Revenue

—

Q3 FY2024

Aug 29, 2024

EPS Actual

—

EPS Est.

—

EPS Surpr.

—

Revenue

—

Q1 FY2024

Mar 28, 2024

EPS Actual

—

EPS Est.

—

EPS Surpr.

—

Revenue

—

Q4 FY2023

Dec 31, 2023

EPS Actual

$35.74

EPS Est.

—

EPS Surpr.

—

Revenue

$0.30B

Q2 FY2023

Jun 30, 2023

EPS Actual

$35.92

EPS Est.

—

EPS Surpr.

—

Revenue

$0.33B

Q4 FY2022

Dec 31, 2022

EPS Actual

$30.29

EPS Est.

—

EPS Surpr.

—

Revenue

$0.31B

Analyst Estimates

EPS Estimates

Period	Low	Consensus	High	# Analysts
Q4 FY2024	$0.00	$0.00	$0.00	0
Q3 FY2024	$0.00	$0.00	$0.00	0

Revenue Estimates

Period	Low	Consensus	High	# Analysts
Q4 FY2024	$5.9B	$5.9B	$5.9B	1
Q3 FY2024	$5.6B	$5.6B	$5.6B	1

Earnings Price Reaction

Closing price one trading day before vs. one trading day after each earnings release.

Period	Report Date	EPS Beat/Miss	Price Before	Price After	1D Reaction
— Q1 FY2026	Mar 26, 2026	—	$19.25	$19.25	+0.00%
— Q4 FY2023	Dec 31, 2023	—	$18.80	$18.80	+0.00%
— Q2 FY2023	Jun 30, 2023	—	$18.80	$18.80	+0.00%
— Q4 FY2022	Dec 31, 2022	—	$12.12	$12.12	+0.00%
— Q2 FY2022	Jun 30, 2022	—	$22.13	$22.13	+0.00%
— Q4 FY2021	Dec 31, 2021	—	$22.13	$22.13	+0.00%
— Q2 FY2021	Jun 30, 2021	—	$22.13	$22.13	+0.00%
— Q4 FY2020	Dec 31, 2020	—	$22.13	$22.13	+0.00%

Q1 FY2026+0.00%

Report Date

Mar 26, 2026

EPS Beat/Miss

—

Price Before

$19.25

Price After

$19.25

Q4 FY2023+0.00%

Report Date

Dec 31, 2023

EPS Beat/Miss

—

Price Before

$18.80

Price After

$18.80

Q2 FY2023+0.00%

Report Date

Jun 30, 2023

EPS Beat/Miss

—

Price Before

$18.80

Price After

$18.80

Q4 FY2022+0.00%

Report Date

Dec 31, 2022

EPS Beat/Miss

—

Price Before

$12.12

Price After

$12.12

Q2 FY2022+0.00%

Report Date

Jun 30, 2022

EPS Beat/Miss

—

Price Before

$22.13

Price After

$22.13

Q4 FY2021+0.00%

Report Date

Dec 31, 2021

EPS Beat/Miss

—

Price Before

$22.13

Price After

$22.13

Q2 FY2021+0.00%

Report Date

Jun 30, 2021

EPS Beat/Miss

—

Price Before

$22.13

Price After

$22.13

Q4 FY2020+0.00%

Report Date

Dec 31, 2020

EPS Beat/Miss

—

Price Before

$22.13

Price After

$22.13

Beat Rate0 / 8 quarters

Largest Move+0.00% (Q1 FY2026)

Data: FMP /historical-price-eod/full · field: close

About Earnings & Data Methodology

China Shineway Pharmaceutical Group Limited (CSWYY) most recently reported earnings on March 26, 2026 for Q1 FY2026, posting EPS of $24.99 (in line with the analyst consensus of —). The next CSWYY earnings date is expected around September 1, 2026.

Each quarter, investors track CSWYY earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. CSWYY revenue tab →

Earnings Glossary

EPS (Earnings Per Share)

Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.

Earnings Surprise %

(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.

Beat / Miss / In-Line

Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.

BMO / AMC

Before Market Open / After Market Close. Two windows when companies typically release results.

Fiscal Quarter

CSWYY's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.

Analyst Consensus

Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.

Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.

Revenue Price history Financial statements Forecast Dividends Market cap

Frequently asked questions

CSWYY earnings · 4 questions

China Shineway Pharmaceutical Group Limited's next earnings report is expected around September 1, 2026. CSWYY typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; CSWYY historically reports after market close (AMC).

CSWYY earnings datewhen is CSWYY earningsCSWYY next earnings datewhen does CSWYY report earningsCSWYY earnings calendar

▸ Source: FMP · China Shineway Pharmaceutical Group Limited SEC filings · US GAAP · China Shineway Pharmaceutical Group Limited SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026